
Burning Rock Biotech Ltd — Investor Relations & Filings
Burning Rock Biotech Ltd. is a global diagnostics company specializing in precision oncology. The company focuses on applying next-generation sequencing (NGS) technology to develop and commercialize solutions for cancer diagnostics. Its portfolio includes NGS-based assays for both tissue and liquid biopsies, designed for cancer therapy selection and early detection. Burning Rock offers solutions covering the entire precision oncology development cycle, supported by an in-house database to facilitate clinical trials and research.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 20-F - Burning Rock Biotech Ltd (0001792267) (Filer) | 2026-04-28 | English | |
| 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-19 | English | |
| 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | |
| 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | |
| 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | |
| 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 37943682 | 20-F - Burning Rock Biotech Ltd (0001792267) (Filer) | 2026-04-28 | English | ||
| 32981146 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-19 | English | ||
| 32964898 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | ||
| 32964752 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | ||
| 32964743 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | ||
| 32964729 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | ||
| 32964721 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | ||
|
2025
8 filings
| |||||
| 13213432 | FORM 6-K | 2025-12-23 | English | ||
| 13213433 | Major Shareholding Notification 2025 | 2025-12-19 | English | ||
| 13213434 | FORM 6-K | 2025-12-01 | English | ||
| 13213435 | FORM 6-K | 2025-11-20 | English | ||
| 13213436 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13213437 | FORM 6-K | 2025-09-08 | English | ||
| 13213438 | FORM 6-K | 2025-06-06 | English | ||
| 13213439 | FORM 20-F | 2025-04-29 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
HeartSciences Inc.
Medical technology company applying AI to electrocardiograp…
|
HSCS | US | Professional, scientific and te… |
|
Heartseed Inc.
Clinical-stage biotech developing regenerative medicine for…
|
219A | JP | Professional, scientific and te… |
|
Hemostemix Inc.
Clinical-stage biotech developing autologous stem cell ther…
|
HEM | CA | Professional, scientific and te… |
|
Herantis Pharma Oyj
A clinical-stage biotech developing therapies for neurodege…
|
HRTIS | FI | Professional, scientific and te… |
|
HEXIMA LIMITED.
Develops plant-derived proteins for human therapeutics and …
|
HXL | AU | Professional, scientific and te… |
|
Hipower Energy Spolka Akcyjna
Develops and commercializes hydrogen-based solutions and fu…
|
HPE | PL | Professional, scientific and te… |
|
HitGen Inc.
Discovers small molecule drug candidates using a DNA-encode…
|
688222 | CN | Professional, scientific and te… |
|
HLB bioStep Co.,Ltd.
A non-clinical CRO providing drug development services, spe…
|
278650 | KR | Professional, scientific and te… |
|
HLB PANAGENE Co., LTD.
Specializes in PNA-based molecular diagnostics for oncology…
|
046210 | KR | Professional, scientific and te… |
|
HLB SCIENCE Inc.
Develops drugs and diagnostics for infectious, immune, and …
|
343090 | KR | Professional, scientific and te… |
Burning Rock Biotech Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34185/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34185 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34185 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34185 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34185}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Burning Rock Biotech Ltd (id: 34185)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.